4//SEC Filing
Dudley Robert Michael 4
Accession 0001104659-23-073872
CIK 0001829635other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 6:23 PM ET
Size
7.0 KB
Accession
0001104659-23-073872
Insider Transaction Report
Form 4
Dudley Robert Michael
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2023-06-20$2.55/sh+6,607$16,847→ 70,262 total - Purchase
Common Stock
2023-06-21$2.65/sh+12,000$31,818→ 82,262 total
Footnotes (2)
- [F1]Reflects the weighted average purchase price for shares of common stock purchased. Actual purchase prices for the shares purchased ranged from $2.54 to $2.55. The Reporting Person undertakes to provide TransCode Therapeutics, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.
- [F2]Reflects the weighted average purchase price for shares of common stock purchased. Actual purchase prices for the shares purchased ranged from $2.60 to $2.70. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Transcode Therapeutics, Inc.
CIK 0001829635
Entity typeother
Related Parties
1- filerCIK 0001854161
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 6:23 PM ET
- Size
- 7.0 KB